{"@id":"https://bioecon.ru/technology/naat-sti-testing/","@type":"Technology","cluster":"diagnostics-medtech","formats":{"html":"https://en.bioecon.ru/technology/naat-sti-testing/","json":"https://en.bioecon.ru/api/v1/technology/naat-sti-testing/index.json"},"id":"naat-sti-testing","industries":["diagnostics","services","research-tools"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/diagnostics/","https://bioecon.ru/industries/services/","https://bioecon.ru/industries/research-tools/"],"suppliers":["https://bioecon.ru/companies/daesang/","https://bioecon.ru/companies/multiplex-group/","https://bioecon.ru/companies/celluranics/","https://bioecon.ru/companies/jindan-lactic-acid/","https://bioecon.ru/companies/compania-de-servicios-tecnicos-integrales-sti-sas/","https://bioecon.ru/companies/afyren/","https://bioecon.ru/companies/ajinomoto-agrosolutions/"]},"maturity":9,"name":"Multiplex Nucleic Acid Amplification Testing for Sexually Transmitted Infections (NAAT STI)","regions":["us","cn","eu"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"cdc.gov","kind":"official","urls":["https://www.cdc.gov/std/treatment-guidelines/naat.htm"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.jcv.2022.105260"]}],"stages":[{"n":1,"title":null},{"n":2,"title":null},{"n":3,"title":null},{"n":4,"title":null},{"n":5,"title":null}],"summary":"High-sensitivity multiplex nucleic acid amplification assays (real-time PCR, TMA, and SDA) detecting Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium from non-invasive urine and self-collected swabs.","url":"/technology/naat-sti-testing/","verified":"2026-11-15"}